Cornerstone Investment Partners LLC purchased a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Co
Caprock Group LLC acquired a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The f
Atria Investments Inc trimmed its stake in Thermo Fisher Scientific Inc. (NYSE: TMO) by 31.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted fo
ABC Arbitrage SA acquired a new position in Thermo Fisher Scientific Inc. (NYSE: TMO) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $3.8 billion aggregate principal amount (the “Offer
Smartleaf Asset Management LLC increased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 33.5% in the third quarter, according to its most recent 13F filing with the Securities
Nuance Investments LLC trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 39.7% in the third quarter, according to the company in its most recent 13F filing with the Securi
Shares of Thermo Fisher Scientific Inc. (NYSE: TMO - Get Free Report) have been given an average rating of "Moderate Buy" by the twenty-two brokerages that are currently covering the company, MarketBe
Insightful Moves in the Fourth Quarter of 2025 Manning and Napier Group, LLC (Trades, Portfolio) recently submitted its 13F filing for the fourth quarter of 2025
Thermo Fisher delivered strong Q1 results, beating expectations with revenue of $12.21B (+7% YoY) and EPS of $6.57 (+8%). I reaffirm my strong buy rating on TMO, setting a target price of $668 per sha
Q4 Revenue: $12.21 billion, up 7% year-over-year.Q4 Adjusted Operating Income: $2.88 billion, up 6% year-over-year.Q4 Adjusted Operating Margin: 23.6%.Q4 Adjus
Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript
Thermo Fisher Scientific Inc.  (NYSE: TMO) on Thursday reported fourth-quarter 2025 adjusted earnings of $6.57 per share, beating the street view of $6.45.
Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) delivered a fourth quarter earnings beat, but its shares moved lower as investors focused on margin pressures and cautious earnings guidance for 2026
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE